Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada
Clinical trial NCT01557400 · COMPLETED
Trial details
- NCT number
- NCT01557400
- Sponsor
- PTC Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-20
- Primary completion
- 2018-01-19
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.